Cookson Peirce & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.6M Sell
227,273
-511
-0.2% -$119K 1.83% 10
2026
Q2
$54.1M Buy
227,784
+963
+0.4% +$200K 1.78% 10
2026
Q1
$47.9M Sell
226,821
-7,240
-3% -$1.56M 2.03% 9
2025
Q4
$48.1M Sell
234,061
-2,246
-1% -$423K 1.99% 10
2025
Q3
$37.1M Sell
236,307
-7,855
-3% -$1.21M 1.52% 19
2025
Q2
$41M Sell
244,162
-1,572
-0.6% -$233K 1.8% 16
2025
Q1
$33.9M Buy
+245,734
New +$31.3M 1.7% 17
2024
Q2
– Sell
-3,243
Closed -$363K – 232
2024
Q1
$363K Buy
3,243
+806
+33% +$87K 0.02% 183
2023
Q4
$246K Buy
+2,437
New +$242K 0.01% 186

Other funds holding CAH

Cookson Peirce & Co's CAH Position: Q3 2026 in Review

Cookson Peirce & Co reduced its Cardinal Health (CAH) stake by 0.22% in Q3 2026, selling an estimated $119K and leaving 227,273 shares worth $50.6M. The position accounts for 1.83% of the portfolio, ranked #10.

Cookson Peirce & Co first reported a position in CAH in Q4 2023 and has held it in 9 quarters since. The position peaked at $54.1M in Q2 2026. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Cookson Peirce & Co held 227,273 shares of Cardinal Health worth $50.6M as of Q3 2026.
  • Cookson Peirce & Co sold 511 Cardinal Health shares in Q3 2026, an estimated $119K.
  • Cardinal Health made up 1.83% of Cookson Peirce & Co's portfolio in Q3 2026, its #10 holding.
  • Cookson Peirce & Co first reported a position in Cardinal Health in Q4 2023 and has held it in 9 quarters since.
  • Cookson Peirce & Co's Cardinal Health position peaked at $54.1M in Q2 2026.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.